197 related articles for article (PubMed ID: 29335817)
1. Repurposing existing drugs for new AMPK activators as a strategy to extend lifespan: a computer-aided drug discovery study.
Mofidifar S; Sohraby F; Bagheri M; Aryapour H
Biogerontology; 2018 Apr; 19(2):133-143. PubMed ID: 29335817
[TBL] [Abstract][Full Text] [Related]
2. In silico Analysis of AMP-activated Protein Kinase and Ligand-based Virtual Screening for Identification of Novel AMPK Activators.
Ghaffar A; Batool S; Mushtaq G; Kamal MA
Curr Comput Aided Drug Des; 2017; 13(3):222-233. PubMed ID: 28294049
[TBL] [Abstract][Full Text] [Related]
3. Performing an In Silico Repurposing of Existing Drugs by Combining Virtual Screening and Molecular Dynamics Simulation.
Sohraby F; Bagheri M; Aryapour H
Methods Mol Biol; 2019; 1903():23-43. PubMed ID: 30547434
[TBL] [Abstract][Full Text] [Related]
4. Adenosine Monophosphate-Activated Protein Kinase (AMPK) as a Diverse Therapeutic Target: A Computational Perspective.
Ramesh M; Vepuri SB; Oosthuizen F; Soliman ME
Appl Biochem Biotechnol; 2016 Feb; 178(4):810-30. PubMed ID: 26541160
[TBL] [Abstract][Full Text] [Related]
5. Repurposing FDA-approved drugs for anti-aging therapies.
Snell TW; Johnston RK; Srinivasan B; Zhou H; Gao M; Skolnick J
Biogerontology; 2016 Nov; 17(5-6):907-920. PubMed ID: 27484416
[TBL] [Abstract][Full Text] [Related]
6. Implementation of a Pipeline Using Disease-Disease Associations for Computational Drug Repurposing.
Balasundaram P; Kanagavelu R; James N; Maiti S; Veerappapillai S; Karuppaswamy R
Methods Mol Biol; 2019; 1903():129-148. PubMed ID: 30547440
[TBL] [Abstract][Full Text] [Related]
7. Targeting of AMP-activated protein kinase: prospects for computer-aided drug design.
Kim J; Yang G; Ha J
Expert Opin Drug Discov; 2017 Jan; 12(1):47-59. PubMed ID: 27797589
[TBL] [Abstract][Full Text] [Related]
8. Discovery of natural adenosine monophosphate‑activated protein kinase activators through virtual screening and activity verification studies.
Hao J; Yang Z; Li J; Han L; Zhang Y; Wang T
Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495803
[TBL] [Abstract][Full Text] [Related]
9. In Silico Drug Repurposing Approach: Investigation of
Ngidi NTP; Machaba KE; Mhlongo NN
Molecules; 2022 Jan; 27(3):. PubMed ID: 35163931
[No Abstract] [Full Text] [Related]
10. Repurposed FDA-approved drugs targeting genes influencing aging can extend lifespan and healthspan in rotifers.
Snell TW; Johnston RK; Matthews AB; Zhou H; Gao M; Skolnick J
Biogerontology; 2018 Apr; 19(2):145-157. PubMed ID: 29340835
[TBL] [Abstract][Full Text] [Related]
11. Computer-aided drug design for AMP-activated protein kinase activators.
Wang Z; Huo J; Sun L; Wang Y; Jin H; Yu H; Zhang L; Zhou L
Curr Comput Aided Drug Des; 2011 Sep; 7(3):214-27. PubMed ID: 21595631
[TBL] [Abstract][Full Text] [Related]
12. Understanding the Mechanism of Direct Activation of AMP-Kinase: Toward a Fine Allosteric Tuning of the Kinase Activity.
Aledavood E; Moraes G; Lameira J; Castro A; Luque FJ; Estarellas C
J Chem Inf Model; 2019 Jun; 59(6):2859-2870. PubMed ID: 30924649
[TBL] [Abstract][Full Text] [Related]
13. Levoleucovorin inhibits LOXL2 (lysyl oxidase like-2) to control breast cancer proliferation: a repurposing approach.
Deshpande H
J Biomol Struct Dyn; 2024 Jul; 42(10):5104-5113. PubMed ID: 37340696
[TBL] [Abstract][Full Text] [Related]
14. Structure investigation, enrichment analysis and structure-based repurposing of FDA-approved drugs as inhibitors of BET-BRD4.
Wakchaure P; Velayutham R; Roy KK
J Biomol Struct Dyn; 2019 Aug; 37(12):3048-3057. PubMed ID: 30079805
[TBL] [Abstract][Full Text] [Related]
15. β-Guanidinopropionic acid extends the lifespan of Drosophila melanogaster via an AMP-activated protein kinase-dependent increase in autophagy.
Yang S; Long LH; Li D; Zhang JK; Jin S; Wang F; Chen JG
Aging Cell; 2015 Dec; 14(6):1024-33. PubMed ID: 26120775
[TBL] [Abstract][Full Text] [Related]
16. Comparing Drug Images and Repurposing Drugs with BioGPS and FLAPdock: The Thymidylate Synthase Case.
Siragusa L; Luciani R; Borsari C; Ferrari S; Costi MP; Cruciani G; Spyrakis F
ChemMedChem; 2016 Aug; 11(15):1653-66. PubMed ID: 27404817
[TBL] [Abstract][Full Text] [Related]
17. In Silico Drug-Target Profiling.
Trosset JY; Cavé C
Methods Mol Biol; 2019; 1953():89-103. PubMed ID: 30912017
[TBL] [Abstract][Full Text] [Related]
18. DrugRep: an automatic virtual screening server for drug repurposing.
Gan JH; Liu JX; Liu Y; Chen SW; Dai WT; Xiao ZX; Cao Y
Acta Pharmacol Sin; 2023 Apr; 44(4):888-896. PubMed ID: 36216900
[TBL] [Abstract][Full Text] [Related]
19. Revisiting Repurposing.
Sharlow ER
Assay Drug Dev Technol; 2016 Dec; 14(10):554-556. PubMed ID: 27982703
[TBL] [Abstract][Full Text] [Related]
20. Predicting new indications for approved drugs using a proteochemometric method.
Dakshanamurthy S; Issa NT; Assefnia S; Seshasayee A; Peters OJ; Madhavan S; Uren A; Brown ML; Byers SW
J Med Chem; 2012 Aug; 55(15):6832-48. PubMed ID: 22780961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
